NEAT1 and nasopharyngeal carcinoma: Furthermore, Liu et al., demonstrated that NEAT1 contributes to cisplatin resistance by modulating Rsf-1 expression and the Ras-MAPK pathway in nasopharyngeal carcinoma [126].